Pennsylvania 2025_0 Regular Session Status: In Committee Bipartisan · 13 R · 9 D cosponsors

HR 157 — A Resolution urging the Congress of the United States to pass H.R. 1947, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act or similar legislation dealing with stellate ganglion block therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder, during the 119th United States Congress.

Last action — Laid on the table (Pursuant to House Rule 71), April 27, 2026

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced March 31, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 23 sponsors

    1 primary, 22 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (13 R · 9 D) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Urging Congress to Pass the PTSD Treatment Act for Veterans

Bill Text

What changed in the latest version

48 added · 49 removed

Plain-language change summary

The bill now urges Congress to support H.R. 3023, which focuses on improving PTSD treatment for veterans by making a specific therapy called stellate ganglion block (SGB) accessible. Additionally, it removed an outdated reference to a different version of H.R. 3023 from 1947, ensuring the language is more relevant to current legislative discussions. These changes are significant because they highlight the urgent need for effective treatments for PTSD, which affects many veterans, and underscores a commitment to address the alarming rates of veteran suicide.

→
Previous
Latest
PRIOR PRINTER'S NO.
PRINTER'S NO.
1186 PRINTER'S NO.
1186 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE RESOLUTION Session of No.
2704 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE RESOLUTION Session of No.
157 2025 INTRODUCED BY ZIMMERMAN, KRUPA, HAMM, FREEMAN, GUENST, JAMES, SCHEUREN, HADDOCK, NEILSON, SCHMITT, COOK, GILLEN AND K.HARRIS, MARCH 31, 2025 REFERRED TO COMMITTEE ON INTERGOVERNMENTAL AFFAIRS AND OPERATIONS, MARCH 31, 2025 A RESOLUTION Urging the Congress of the United States to pass H.R.
157 2025 INTRODUCED BY ZIMMERMAN, KRUPA, HAMM, FREEMAN, GUENST, JAMES, WEAKNECHT, RUSNOCK, CEPEDA-FREYTIZ, MALONEY, BARTON, WATRO,S, BOROWSKI, KLUNK AND PUGH, MARCH 31, 2025 AS OPERATIONS, HOUSE OF REPRESENTATIVES, AS AMENDED,IRS AND DECEMBER 15, 2025 A RESOLUTION Urging the Congress of the United States to pass H.R.
3023, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, should it be reintroduced, or similar veterans and members of the armed forces of the United States with post-traumatic stress disorder, during the 119th United States Congress.
3023 1947, <-- the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, should it be reintroduced, or similar <-- legislation dealing with stellate ganglion block therapy to veterans and members of the armed forces of the United States States Congress.tic stress disorder, during the 119th United WHEREAS, H.R.
WHEREAS, H.R.
3023 1947 directs the United States Secretary <-- of Veterans Affairs and the United States Secretary of Defense to furnish stellate ganglion block (SGB) therapy to veterans and members of the armed forces of the United States with post- traumatic stress disorder (PTSD);
3023 directs the United States Secretary of Veterans Affairs and the United States Secretary of Defense to furnish stellate ganglion block (SGB) therapy to veterans and members of the armed forces of the United States with post- traumatic stress disorder (PTSD);
3023 1947 is supported by the Pennsylvania <-- National Guard Associations, the American Legion and behavioral health clinicians;
3023 is supported by the Pennsylvania National Guard Associations, the American Legion and behavioral health clinicians;
3023 1947, the Treatment and Relief through <-- Emerging and Accessible Therapy for PTSD Act, should it be <-- reintroduced, or similar legislation dealing with stellate ganglion block therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder, during the 119th United States Congress;
3023, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, should it be reintroduced, or similar legislation dealing with stellate ganglion block therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder, during the 119th United States Congress;
and be it further RESOLVED, That copies of this resolution be transmitted to 20250HR0157PN2704 - 2 - the President of the United States, the presiding officers of each house of Congress and to each member of Congress from Pennsylvania.
and be it further RESOLVED, That copies of this resolution be transmitted to the President of the United States, the presiding officers of 20250HR0157PN1186 - 2 - each house of Congress and to each member of Congress from Pennsylvania.
20250HR0157PN2704 - 3 -
20250HR0157PN1186 - 3 -
View plain text versions (2)

Action History

  1. Laid on the table (Pursuant to House Rule 71), April 27, 2026

  2. Reported as amended, Dec. 15, 2025

  3. Referred to INTERGOVERNMENTAL AFFAIRS AND OPERATIONS, March 31, 2025

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 22 co-sponsors · 230 not signed on

Sponsors (1)

Co-sponsors (22)

Not signed on (230)

230 members have not signed on to this bill.

Show all 230 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 157 do?
Urging Congress to Pass the PTSD Treatment Act for Veterans
Who sponsors HR 157?
HR 157 is sponsored by Eric J. Weaknecht (Republican), David H. Zimmerman (Republican), Keith S. Harris (Democratic), Charity Grimm Krupa (Republican), Joe Hamm (Republican), Robert Freeman (Democratic), Nancy Guenst (Democratic), R. Lee James (Republican), Donna Scheuren (Republican), Jim Haddock (Democratic), Ed Neilson (Democratic), Bud Cook (Republican), Mark M. Gillen (Republican), Jacklyn Rusnock (Democratic), Johanny Cepeda-Freytiz (Democratic), David M. Maloney (Republican), Jamie Barton (Republican), Dane Watro (Republican), Lisa A. Borowski (Democratic), Kate A. Klunk (Republican), Brenda M. Pugh (Republican), Manuel Guzman (Democratic), and Louis Schmitt.
What is the current status of HR 157?
This bill is in committee in the House. Introduced March 31, 2025. It must pass committee before a floor vote.
Where can I track HR 157?
Track HR 157 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 157

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HR 157

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →